| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Healthcare sector), PBLS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 26.53M | $789.79M | - | |
| 10% | 1.03M | $20.54M | - | |
| Dir | 105.4K | - | - | |
| Dir | 25.9K | $674.3K | - | |
| Dir | 20.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 244,593 | $28.29 | $6,919,551.27 | +0.9% | |
| Jun 15, 2026 | Sebulsky Alan | Director | Buy | 17,500 | $27.06 | $473,528.54 | +140.0% | |
| Jun 11, 2026 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 21,188,750 | $20.00 | $423,775,000.00 | -114.3% | |
| Jun 11, 2026 | Levy Guy | 10% Owner | Buy | 500,000 | $20.00 | $10,000,000.00 | +328.9% | |
| Jun 11, 2026 | Sebulsky Alan | Director | Buy | 12,500 | $20.00 | $250,000.00 | New |